Review Article
Published: 26 August, 2025 | Volume 9 - Issue 1 | Pages: 042-045
Pharmacovigilance is concerned with the adverse effects of the authorized drugs after use, hence if the adverse effects are harmful and deteriorate other organs or tissues of the patient.
These adverse effects were reported by the patients, pharmacists, nurses, clinicians, and physicians. Some examples which withdrawal from the markets according to the pharmacovigilance: astemizole, cisapride, terfenadine, and rofecoxib, which revealed many adverse effects leading to their withdrawal these drugs from the markets.
Aim of the research: The knowledge around pharmacovigilance and improving the side effects of drugs which present in the market, the results of this improvement led us to obtain new drugs without serious side effects.
We conclude that the market drugs improved from the older drugs, have side effects will are suitable to the usage by patients.
Read Full Article HTML DOI: 10.29328/journal.apps.1001069 Cite this Article Read Full Article PDF
Pharmacovigilance; Drug-related problems: Adverse effects; Drug-health care information; Patients; Nurses; Pharmacists; Physicians; Drug production companies
Figure 1
Figure 2
Figure 3
Figure 4
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."